Vaccination against tick-borne encephalitis under therapeutic immunosuppression. Reduced efficacy in heart transplant recipients.

[1]  Y. Shoenfeld,et al.  Vaccine-induced autoimmunity. , 1996, Journal of autoimmunity.

[2]  O. Girgsdies,et al.  Tick-borne encephalitis: development of a paediatric vaccine. A controlled, randomized, double-blind and multicentre study. , 1996, Vaccine.

[3]  F. Hayden,et al.  The immunogenicity of influenza virus vaccine in solid organ transplant recipients. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  L. Lindquist,et al.  A 10-year follow-up study of tick-borne encephalitis in the Stockholm area and a review of the literature: need for a vaccination strategy. , 1996, Scandinavian journal of infectious diseases.

[5]  K. Theobald,et al.  Vaccination against tick-borne encephalitis (TBE): influence of simultaneous application of TBE immunoglobulin on seroconversion and rate of adverse events. , 1995, Vaccine.

[6]  A. Teufel,et al.  Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity. , 1994, The Journal of rheumatology.

[7]  W. Petri,et al.  Infections in heart transplant recipients. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  C. Dioudis,et al.  Influenza vaccination on renal transplant patients is safe and serologically effective. , 1993, International journal of clinical pharmacology, therapy, and toxicology.

[9]  J. Kobashigawa,et al.  Influenza vaccine does not cause rejection after cardiac transplantation. , 1993, Transplantation proceedings.

[10]  P. Whitington,et al.  Measles vaccination after orthotopic liver transplantation. , 1993, The Journal of pediatrics.

[11]  M. D. de Broe,et al.  Immunogenicity of a recombinant DNA hepatitis B vaccine in renal transplant patients. , 1993, Vaccine.

[12]  M. Eibl,et al.  Cellular and humoral immune responses in haemophiliacs after vaccination against tick‐borne encephalitis , 1992, British journal of haematology.

[13]  U. Klockmann,et al.  A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens. , 1992, Vaccine.

[14]  W. Carey,et al.  Failure of hepatitis B immunization in liver transplant recipients: results of a prospective trial. , 1990, The American journal of gastroenterology.

[15]  M. Hammond,et al.  A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. , 1990, The Journal of heart transplantation.

[16]  U. Klockmann,et al.  A new vaccine against tick-borne encephalitis: initial trial in man including a dose-response study. , 1990, Vaccine.

[17]  W. Graninger,et al.  Infectious complications in heart transplant recipients with combined low dose cyclosporine, azathioprine and prednisolone (triple drug) immunosuppression. , 1989, Transplantation proceedings.

[18]  U. Klockmann,et al.  Preclinical investigations of the safety, immunogenicity and efficacy of a purified, inactivated tick-borne encephalitis vaccine. , 1989, Journal of biological standardization.

[19]  M. Eibl,et al.  Impaired primary, but not secondary, immune response in breast cancer patients under adjuvant chemotherapy , 1986, Cancer.

[20]  F. Heinz,et al.  A topological and functional model of epitopes on the structural glycoprotein of tick-borne encephalitis virus defined by monoclonal antibodies. , 1983, Virology.

[21]  F. Heinz,et al.  Preparation of a highly purified vaccine against tick‐borne encephalitis by continuous flow zonal ultracentrifugation , 1980, Journal of medical virology.

[22]  F. Heinz,et al.  Immunogenicity and reactogenicity of a highly purified vaccine against tick‐borne encephalitis , 1980, Journal of medical virology.